Abstract:Prodigiosin, a secondary metabolite produced by Serratia marcescens , has attracted attention due to its immunosuppressive, antimicrobial, and anticancer properties. However, information on the regulatory mechanism behind prodigiosin biosynthesis in S. marcescens remains limited. In this work, a prodigiosin-hyperproducing strain with the BVG90_22495 gene disrupted (ZK66) was selected from a collection of Tn 5 G transposon insertion mutants. Using real-time quantitative PCR (RT-qPCR) analysis, β-galactosidase assays, transcriptomics analysis, and electrophoretic mobility shift assays (EMSAs), the LysR-type regulator MetR encoded by the BVG90_22495 gene was found to affect prodigiosin synthesis, and this correlated with MetR directly binding to the promoter region of the prodigiosin-synthesis positive regulator PigP and hence negatively regulated the expression of the prodigiosin-associated pig operon. More analyses revealed that MetR regulated some other important cellular processes, including methionine biosynthesis, cell motility, H 2 O 2 tolerance, heat tolerance, exopolysaccharide synthesis, and biofilm formation in S. marcescens . Although MetR protein is highly conserved in many bacteria, we report here on the LysR-type regulator MetR exhibiting novel roles in negatively regulating prodigiosin synthesis and positively regulating heat tolerance, exopolysaccharide synthesis, and biofilm formation. IMPORTANCE Serratia marcescens , a Gram-negative bacterium, is found in a wide range of ecological niches and can produce several secondary metabolites, including prodigiosin, althiomycin, and serratamolide. Among them, prodigiosin shows diverse functions as an immunosuppressant, antimicrobial, and anticancer agent. However, the regulatory mechanisms behind prodigiosin synthesis in S. marcescens are not completely understood. Here, we adapted a transposon mutant library to identify the genes related to prodigiosin synthesis, and the BVG90_22495 gene encoding the LysR-type regulator MetR was found to negatively regulate prodigiosin synthesis. The molecular mechanism of the metR mutant hyperproducing prodigiosin was investigated. Additionally, we provided evidence supporting new roles for MetR in regulating methionine biosynthesis, cell motility, heat tolerance, H 2 O 2 tolerance, and exopolysaccharide synthesis in S. marcescens . Collectively, this work provides novel insight into regulatory mechanisms of prodigiosin synthesis and uncovers novel roles for the highly conserved MetR protein in regulating prodigiosin synthesis, heat tolerance, exopolysaccharide (EPS) synthesis, and biofilm formation.

Characterization of Serratia marcescens (OK482790)' prodigiosin along with in vitro and in silico validation for its medicinal bioactivities

Isolation, Identification, and Antimicrobial Evaluation of Secondary Metabolite from Serratia marcescens via an In Vivo Epicutaneous Infection Model

Isolation, Identification, and Antibacterial Properties of Prodigiosin, a Bioactive Product Produced by a New Serratia marcescens JSSCPM1 Strain: Exploring the Biosynthetic Gene Clusters of Serratia Species for Biological Applications

Anticancer and Immunomodulatory Activities of Prodigiosin Extracted and Purified from Serratia marcescens

Physical and chemical stress on Serratia marcescens and studies on prodigiosin pigment production

Isolation and identification of Serratia marcescens producing high levels of prodigiosin and its fermentation optimization

Characterization and Enhanced Production of Prodigiosin from the Spoiled Coconut

Prodigiosin inhibits bacterial growth and virulence factors as a potential physiological response to interspecies competition

Antibacterial Activity of a Novel Depsipeptide and Prodigiosine of Serratia Marcescans S823

Prodigiosin production and recovery from Serratia marcescens: process development and cost–benefit analysis

Isolation of Serratia Marcescens from the Soil and In vitro Prodigiosin Production as Source of Antibiotic, Active against Oxacillin-Resistant Staphylococcus aureus

High‐level production of microbial prodigiosin: A review

Recent advancements in high-level synthesis of the promising clinical drug, prodigiosin

Study on the Anticancer Activity of Prodigiosin from Variants of Serratia Marcescens QBN VTCC 910026

Recent Advances in Prodigiosin as a Bioactive Compound in Nanocomposite Applications

Improving prodigiosin production by transcription factor engineering and promoter engineering in Serratia marcescens

Prodigiosin of Serratia marcescens ZPG19 Alters the Gut Microbiota Composition of Kunming Mice

Activity Evaluation and Bibliometric Analysis of an Antibacterial Drug

Prodigiosin: unveiling the crimson wonder – a comprehensive journey from diverse bioactivity to synthesis and yield enhancement

Optimization of the Culture Condition for an Antitumor Bacterium Serratia Proteamacula 657 and Identification of the Active Compounds.

LysR-Type Transcriptional Regulator MetR Controls Prodigiosin Production, Methionine Biosynthesis, Cell Motility, H2O2 Tolerance, Heat Tolerance, and Exopolysaccharide Synthesis in Serratia marcescens